WORCESTER, Mass., June 26, 2008 (PRIME NEWSWIRE) -- Antigen Express, Inc. (www.antigenexpress.com), the wholly-owned immunotherapeutics subsidiary of Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), has signed a second collaboration agreement with the Mayo Clinic (www.mayoclinic.com). Antigen Express previously entered into an agreement with the Mayo Clinic to work with Dr. Keith Knutson, a leader in the field of peptide vaccines in breast cancer. The current agreement focuses on advancing an immunotherapeutic vaccine for melanoma into the clinic with Dr. Svetomir Markovic, a distinguished translational researcher with expertise in melanoma trials.
